Evidence map›Paper›PMID 32377731›Full record

ArticleOncology reports2020

VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells.

Soteroula Thrasyvoulou, Georgios Vartholomatos, Georgios Markopoulos, Dimitrios Noutsopoulos, Stefania Mantziou, Foteini Gkartziou, Panagiotis Papageorgis, Antonia Charchanti, Panos Kouklis, Andreas I Constantinou and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Soteroula ThrasyvoulouLaboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Georgios VartholomatosLaboratory of Hematology, Unit of Molecular Biology, University Hospital of Ioannina, 45110 Ioannina, Greece.
Georgios MarkopoulosLaboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Dimitrios NoutsopoulosLaboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Stefania MantziouLaboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Foteini GkartziouLaboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Panagiotis PapageorgisBiological Sciences Program, Department of Life Sciences, School of Sciences, European University Cyprus, 2404 Nicosia, Cyprus.
Antonia CharchantiLaboratory of Anatomy‑Histology‑Embryology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Panos KouklisLaboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Andreas I ConstantinouDepartment of Biological Sciences, Faculty of Pure and Applied Sciences, University of Cyprus, 1678 Nicosia, Cyprus.
Theodore TzavarasLaboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
University of Ioannina · GREuropean University Cyprus · CYUniversity Hospital of Ioannina · GRUniversity of Cyprus · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retrotransposons copy their sequences via an RNA intermediate, followed by reverse transcription into cDNA and random insertion, into a new genomic locus. New retrotransposon copies may lead to cell transformation and/or tumorigenesis through insertional mutagenesis. Methylation is a major defense mechanism against retrotransposon RNA expression and retrotransposition in differentiated cells, whereas stem cells are relatively hypo‑methylated. Epithelial‑to‑mesenchymal transition (EMT), which transforms normal epithelial cells into mesenchymal‑like cells, also contributes to tumor progression and tumor metastasis. Cancer stem cells (CSCs), a fraction of undifferentiated tumor‑initiating cancer cells, are reciprocally related to EMT. In the present study, the outcome of long terminal repeat (LTR)‑Viral‑Like 30 (VL30) retrotransposition was examined in mouse mammary stem‑like/progenitor HC11 epithelial cells. The transfection of HC11 cells with a VL30 retrotransposon, engineered with an EGFP‑based retrotransposition cassette, elicited a higher retrotransposition frequency in comparison to differentiated J3B1A and C127 mouse mammary cells. Fluorescence microscopy and PCR analysis confirmed the specificity of retrotransposition events. The differentiated retrotransposition‑positive cells retained their epithelial morphology, while the respective HC11 cells acquired mesenchymal features associated with the loss of E‑cadherin, the induction of N‑cadherin, and fibronectin and vimentin protein expression, as well as an increased transforming growth factor (TGF)‑β1, Slug, Snail‑1 and Twist mRNA expression. In addition, they were characterized by cell proliferation in low serum, and the acquisition of CSC‑like properties indicated by mammosphere formation under anchorage‑independent conditions. Mammospheres exhibited an increased Nanog and Oct4 mRNA expression and a CD44+/CD24‑/low antigenic phenotype, as well as self‑renewal and differentiation capacity, forming mammary acini‑like structures. DNA sequencing analysis of retrotransposition‑positive HC11 cells revealed retrotransposed VL30 copies integrated at the vicinity of EMT‑, cancer type‑ and breast cancer‑related genes. The inoculation of these cells into Balb/c mice produced cytokeratin‑positive tumors containing pancytokeratin‑positive cells, indicative of cell invasion features. On the whole, the findings of the present study demonstrate, for the first time, to the best of our knowledge, that stem‑like epithelial HC11 cells are amenable to VL30 retrotransposition associated with the induction of EMT and CSC generation, leading to tumorigenesis.

Indexed as

RetroelementsAnimalsBiomarkers, TumorCell LineCell ProliferationCell Transformation, NeoplasticEpithelial-Mesenchymal TransitionFemaleMammary Neoplasms, ExperimentalMiceMice, Inbred BALB CNeoplasm TransplantationNeoplastic Stem CellsTransfectionBiomarkers, TumorRetroelementscancer stem cellsepithelial-to-mesenchymal transitionHC11 mammary stem-like cellstumorigenesisVL30 retrotransposition

Identifiers

PMID32377731
PMCPMC7251778
OpenAlexW3022193353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.